The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 01, 2017

Filed:

Dec. 19, 2014
Applicant:

Palo Alto Research Center Incorporated, Palo Alto, CA (US);

Inventors:

Scott A. Uhland, San Jose, CA (US);

Ramkumar Abhishek, Mountain View, CA (US);

Eric Peeters, Mountain View, CA (US);

Timothy J. Curley, San Carlos, CA (US);

Felicia Linn, San Jose, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 5/14 (2006.01); A61M 5/155 (2006.01); A61M 31/00 (2006.01); A61B 17/43 (2006.01); A61K 9/00 (2006.01); A61D 7/00 (2006.01); A61M 5/145 (2006.01); A61M 5/168 (2006.01); A61M 5/142 (2006.01);
U.S. Cl.
CPC ...
A61B 17/43 (2013.01); A61D 7/00 (2013.01); A61K 9/0004 (2013.01); A61K 9/0034 (2013.01); A61M 5/145 (2013.01); A61M 5/1408 (2013.01); A61M 5/155 (2013.01); A61M 5/16827 (2013.01); A61M 31/00 (2013.01); A61M 2005/14204 (2013.01); A61M 2210/1042 (2013.01); A61M 2210/1085 (2013.01); A61M 2210/1433 (2013.01); A61M 2210/1475 (2013.01);
Abstract

Devices and methods are provided for drug delivery. The device may include a housing configured for intraluminal deployment into a human or animal subject and first and second reservoirs within the housing, each reservoir having an actuation end, an opposed release end, and a plug moveable from the actuation end toward the release end. First and second drug formulations may be contained in the first and second reservoirs, respectively. The device may also include one or more actuation systems configured to drive the first and second plugs so as to drive the first and second drug formulations from the first and second reservoirs. The housing may include a porous membrane sidewall in fluid communication with the release ends of the first and second reservoirs, the porous membrane sidewall being configured to distribute the first and second drug formulations driven from the first and second reservoirs.


Find Patent Forward Citations

Loading…